2024-05-15 10:11:37 ET
Summary
- Amphastar Pharmaceuticals, Inc. stock is down approximately 30% this year, and the company reported mixed Q1 results last week.
- Despite the poor performance of the stock so far in 2024, there are some positives on the company and its stock.
- An updated analysis around Amphastar Pharmaceuticals follows in the paragraphs below.
Today, we take our first look at Amphastar Pharmaceuticals, Inc. ( AMPH ) in 2024. The stock of this biopharma concern is down some 30% year to date, and the company reported mixed Q1 results last week. Where do the shares go from here? An updated analysis follows below....
Read the full article on Seeking Alpha
For further details see:
Reassessing Amphastar Pharmaceuticals